Skip to content

Evaluation of the quality of scars resulting from the treatment of burn sequelae with or without the use of dermal matrices

Evaluation of clinical and biomechanical features of scars comparing dermal matrices in burns sequelae

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-3v26fm
Enrollment
Unknown
Registered
2018-10-15
Start date
2017-05-05
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Burn sequelae

Interventions

Patients with burn sequelae with aesthetic impairment or functional restriction with indication of treatment will undergo surgery for correction of the sequel using partial skin graft with or without
Biological/vaccine
Procedure/surgery
C05.550.323

Sponsors

Hospital das clínicas da faculdade de medicina de Ribeirão Preto da Universidade de São Paulo
Lead Sponsor
Hospital das clínicas da faculdade de medicina de Ribeirão Preto da Universidade de São Paulo
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Patients with a burn sequel with aesthetic impairment or functional restriction, with at least one year of post-burn follow-up, with indication of surgical treatment using partial skin graft with or without dermal matrix. In addition, patients included should have at least one hypertrophic scar from the burn, for purposes of comparison between study groups.

Exclusion criteria

Exclusion criteria: Patients who eventually lose follow up or who progress with a loss of more than 10% of the partial skin graft at the time of surgical treatment of the burn sequel will be excluded.

Design outcomes

Primary

MeasureTime frame
The expected outcome according to the literature is that the scars resulting from the surgical treatment of burn sequelae with the use of dermal matrices have a better tissue quality. This comparison will be made between the groups using matrix and the control group that did not use it by evaluating clinical characteristics through Vancouver scar scale and biomechanical characteristics through the durometer and Cutometer® appliances after 6 months postoperatively.

Secondary

MeasureTime frame
Secondary outcomes are not expected

Countries

Brazil

Contacts

Public ContactIvan Almeida

Hospital das clínicas da faculdade de medicina de Ribeirão Preto da Universidade de São Paulo

ivan.rezende.a@gmail.com+5516988238802

Outcome results

None listed

Source: REBEC (via WHO ICTRP)